We are looking for 2 to 17 years of age to join a clinical trial to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or UC (including associated symptoms such as rectal bleeding, fistula, bloody stool, malnutrition and/or liver disease), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to take part.
